189 related articles for article (PubMed ID: 8910508)
21. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230.
Carlson SA; Chatterjee TK; Fisher RA
Recept Signal Transduct; 1996; 6(2):111-20. PubMed ID: 9015866
[TBL] [Abstract][Full Text] [Related]
22. Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants.
Zhelev DV; Alteraifi AM; Chodniewicz D
Biophys J; 2004 Jul; 87(1):688-95. PubMed ID: 15240502
[TBL] [Abstract][Full Text] [Related]
23. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
[TBL] [Abstract][Full Text] [Related]
24. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions.
Richardson RM; DuBose RA; Ali H; Tomhave ED; Haribabu B; Snyderman R
Biochemistry; 1995 Oct; 34(43):14193-201. PubMed ID: 7578017
[TBL] [Abstract][Full Text] [Related]
25. Desensitization by protein kinase C activation differentially uncouples formyl peptide receptors from effector enzymes in HL-60 granulocytes.
Lederer ED; Jacobs AA; McLeish KR
Cell Signal; 1993 Nov; 5(6):735-45. PubMed ID: 8130077
[TBL] [Abstract][Full Text] [Related]
26. Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor.
Hagi A; Hayashi H; Kishi K; Wang L; Ebina Y
J Med Invest; 2000 Feb; 47(1-2):19-28. PubMed ID: 10740976
[TBL] [Abstract][Full Text] [Related]
27. G protein-mediated receptor-receptor interaction: studies with chemotactic receptors in membranes of human leukemia (HL 60) cells.
Wieland T; Gierschik P; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):475-81. PubMed ID: 1470218
[TBL] [Abstract][Full Text] [Related]
28. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor.
Lukashova V; Asselin C; Krolewski JJ; Rola-Pleszczynski M; Stanková J
J Biol Chem; 2001 Jun; 276(26):24113-21. PubMed ID: 11309383
[TBL] [Abstract][Full Text] [Related]
29. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants.
Verghese MW; Charles L; Jakoi L; Dillon SB; Snyderman R
J Immunol; 1987 Jun; 138(12):4374-80. PubMed ID: 3108387
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
31. Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants.
Klinker JF; Schwaner I; Offermanns S; Hagelüken A; Seifert R
Biochem Pharmacol; 1994 Nov; 48(10):1857-64. PubMed ID: 7986196
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a 64-kd protein phosphorylated during chemotactic activation with IL-8 and fMLP of human polymorphonuclear leukocytes. I. Phosphorylation of a 64-kd protein and other proteins.
Shibata M; Ohoka T; Mizuno S; Suzuki K
J Leukoc Biol; 1993 Jul; 54(1):1-9. PubMed ID: 8393062
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2.
Richardson RM; Pridgen BC; Haribabu B; Snyderman R
J Biol Chem; 2000 Mar; 275(13):9201-8. PubMed ID: 10734056
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction in cells following binding of chemoattractants to membrane receptors.
Dillon SB; Verghese MW; Snyderman R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(2):65-80. PubMed ID: 2901161
[TBL] [Abstract][Full Text] [Related]
35. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motif.
Chen Z; Dupré DJ; Le Gouill C; Rola-Pleszczynski M; Stanková J
J Biol Chem; 2002 Mar; 277(9):7356-62. PubMed ID: 11729201
[TBL] [Abstract][Full Text] [Related]
36. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes.
Zhuang Q; Bastien Y; Mazer BD
J Immunol; 2000 Sep; 165(5):2423-31. PubMed ID: 10946267
[TBL] [Abstract][Full Text] [Related]
37. The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins. Studies using intracellular domain minigenes and receptor chimeras.
Carlson SA; Chatterjee TK; Fisher RA
J Biol Chem; 1996 Sep; 271(38):23146-53. PubMed ID: 8798508
[TBL] [Abstract][Full Text] [Related]
38. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
Tardif M; Mery L; Brouchon L; Boulay F
J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
[TBL] [Abstract][Full Text] [Related]
39. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
[TBL] [Abstract][Full Text] [Related]
40. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Shukla SD; Morrison WJ; Dhar A
Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
